Ipamorelin 5mg

Ipamorelin is a pentapeptide growth hormone-releasing peptide (GHRP) and selective agonist of the ghrelin (GHS-R1a) receptor. It is widely cited for its capacity to stimulate pituitary GH release without the cortisol, prolactin or aldosterone elevations associated with earlier GHRPs, making it a clean reference ligand in somatotropic and receptor-selectivity research. The 5mg presentation supports pilot characterisation of GH-release dynamics and ghrelin pathway investigation.

Supplied as a lyophilised peptide vial, supplied for reconstitution with bacteriostatic water. The 5mg size suits pilot studies, receptor-binding assays and dose-ranging experiments where conservation of working stock between protocol revisions is a priority.

Research Applications • Selective ghrelin (GHS-R1a) receptor agonism characterisation • Pituitary growth hormone release profile and amplitude studies • Cortisol, prolactin and aldosterone selectivity comparison research • Combined GHRH-GHRP synergistic GH-release investigation

Specification • Identity: Ipamorelin (CAS 170851-70-4) • Molecular weight: 711.86 g/mol • Purity: 99%+ verified by HPLC and Mass Spectrometry • Format: lyophilised peptide vial — reconstitute with bacteriostatic water before use • Storage: store lyophilised at -20°C; once reconstituted, refrigerate at 2-8°C and use within 4-6 weeks; protect from light

For research use only — not for human consumption.